Rocket Pharmaceuticals, Inc.
RCKT
$4.87
$0.142.96%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.54M | -50.33M | -68.92M | -61.33M | -60.33M |
| Total Depreciation and Amortization | 2.22M | 3.24M | 2.58M | 2.99M | 2.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.29M | 8.16M | 8.65M | 8.26M | 9.86M |
| Change in Net Operating Assets | 195.00K | -11.49M | 8.73M | -5.70M | 1.16M |
| Cash from Operations | -34.84M | -50.42M | -48.96M | -55.79M | -46.94M |
| Capital Expenditure | -80.00K | 54.00K | -50.00K | -364.00K | -309.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.51M | 93.56M | 31.81M | -57.67M | -37.56M |
| Cash from Investing | 36.43M | 93.62M | 31.76M | -58.04M | -37.87M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 182.85M |
| Repurchase of Common Stock | 0.00 | -67.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 215.00K | -- | -- |
| Cash from Financing | 0.00 | -67.00K | 215.00K | -- | 182.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.59M | 43.13M | -16.99M | -113.83M | 98.04M |